Arbutus, Genevant reject Moderna’s vaccine patent defence

07-06-2022

Sarah Speight

Arbutus, Genevant reject Moderna’s vaccine patent defence

T. Schneider / Shutterstock.com

Moderna’s bid to avoid a COVID-19 patent claim has been rejected by two pharma companies that are suing the vaccine manufacturer for infringing its drug delivery technology.


Moderna, COVID-19, Arbutus, Genevant, Section 1498, US government

LSIPR